FDA 510(k)
FDA class 2
Substantially Equivalent
🇫🇷 France
VIDAS FT4
K Number: K132058
·
Decision Jun 8, 2015
Classifications
1
FEI Numbers
43
Registration Numbers
43
Same Product Code
91
Applicant Total
16
Review Days
705
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- VIDAS FT4
- K Number
- K132058
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.1695
- Medical Specialty
- Clinical Chemistry
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Biomerieux S.A.
- Date Received
- July 3, 2013
- Decision Date
- June 8, 2015
- Product Code
- CEC
- Advisory Committee
- Clinical Chemistry
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| CEC | Radioimmunoassay, Free Thyroxine | FDA class 2 | Clinical Chemistry |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (CEC), ordered by most recent decision date.
Access Free T4
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Elecsys FT4 IV
FDA 510(k)
FDA Class 2
·Clinical Chemistry
MAGLUMI 2000 FT4
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Elecsys FT4 III
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Abbott Architect Free T4
FDA 510(k)
FDA Class 2
·Clinical Chemistry
FREND Free T4 Test System
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Other Clearances by Biomerieux S.A.
| K Number | Device Name | ||
|---|---|---|---|
| K250274 | ETEST Imipenem/Relebactam P. aeruginosa (IRPA) (0.008/4-128/4 µg/mL) | Apr 30, 2025 | Substantially Equivalent |
| K210757 | ETEST Fosfomycin (FO) (0.032-512 µg/mL) | Nov 12, 2021 | Substantially Equivalent |
| K192738 | ETEST Delafloxacin (DFX) (0.002-32 µg/mL) | Nov 26, 2019 | Substantially Equivalent |
| K192050 | ETEST Eravacycline (ERV) (0.002 32 µg/mL) | Sep 27, 2019 | Substantially Equivalent |
| K191953 | ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) | Aug 22, 2019 | Substantially Equivalent |
| K190154 | ETEST Piperacillin/Tazobactam (P/T) (0.016/4-256/4 ug/mL) | May 1, 2019 | Substantially Equivalent |
| K183031 | ETEST Meropenem/Vaborbactam (MEV) (0.004/8-64/8 µg/mL) | Jan 11, 2019 | Substantially Equivalent |
| K181092 | CHROMID CARBA agar (CARB) | Jul 6, 2018 | Substantially Equivalent |
| K180936 | ETEST Telavancin (TLA) (0.002-32 ug/mL) | Jul 3, 2018 | Substantially Equivalent |
| K162385 | RAPIDEC CARBA NP | Apr 27, 2017 | Substantially Equivalent |